الفهرس 
abstractOnly 14 pages are availabe for public view
 |  | from | 331 |  |  |
| | | from | 331 | | |
Abstract
Renal impairment is an important feature of diabetes mellitus, causing a significant morbidity and mortality, and much effort has been devoted to the detection of this complication at a stage when it is silent and potentially reversible.
The protease inhibitor Cystatin C is a non-glycosylated low molecular weight protein. Cystatin C has been proposed to be a marker as it is produced by all nucleated cells at a constant rate and is freely filtered by the glomeruli and completely catabolized in the proximal tubules.
The aim of this study is to evaluate serum cystatin C as a marker of early renal affection in type 2 diabetic patients.
To achieve this goal, this study was performed on 80 type 2 diabetic patients and were compared with 20 healthy subjects of matched age, sex and BMI as a control group.